Cargando…
Clopidogrel Loading Dose 300 vs. 600 mg in Patients Undergoing One-Stop Hybrid Coronary Revascularization: A Prospective Single-Center Randomized Pilot Study
Background: The optimal loading dose of clopidogrel in one-stop hybrid coronary revascularization (HCR) remains an “evidence-free” zone. This study aimed to compare the major bleeding and ischemic thrombotic events between different clopidogrel loading doses (300 vs. 600 mg) in one-stop HCR. Methods...
Autores principales: | Guo, Yulin, Li, Dongjie, Gao, Yingdi, Zhao, Jing, An, Xiangguang, Liu, Yan, Gu, Song, Zhang, Xitao, Gao, Jie, Su, Pixiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554050/ https://www.ncbi.nlm.nih.gov/pubmed/34722627 http://dx.doi.org/10.3389/fsurg.2021.768860 |
Ejemplares similares
-
One-Stop Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass Grafting in Patients With Multivessel Coronary Artery Disease
por: Li, Dongjie, et al.
Publicado: (2021) -
Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina
por: Cakal, Sinem, et al.
Publicado: (2021) -
miR-451 on Myocardial Ischemia-Reperfusion in Rats by Regulating AMPK Signaling Pathway
por: Guo, Yulin, et al.
Publicado: (2021) -
An examination of causal associations and shared risk factors for diabetes and cardiovascular diseases in the East Asian population: A Mendelian randomization study
por: Guo, Yulin, et al.
Publicado: (2023) -
Outcomes of left internal mammary artery with saphenous vein composite graft to bypass the left anterior descending artery: a propensity-matched study
por: Li, Dongjie, et al.
Publicado: (2020)